This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Percent of adults diagnosed with a new episode of depression and initiated on an antidepressant drug who received a continuous trial of medication treatment during the acute treatment phase.
National Committee for Quality Assurance, Health Plan Employer Data Information Set (HEDIS) measure.
1.66 Percent of adults diagnosed with a new episode of depression who received a continuous trial of medication during the acute treatment phase, United States, 1998 - 2001.
National Committee for Quality Assurance. HEDIS data from The State of Health Care Quality, 2002.
U.S. enrollees of Medicaid, Medicare or commercial health plans, age 18 and over, with a pharmacy benefit, diagnosed with a new episode of major depression (ICD-9 codes 296.2, 296.3, 298.0, 300.4, 309.1, 311).
Subset of denominator receiving a continuous trial of antidepressant medication treatment during the acute treatment phase (first 12 weeks following initial diagnosis).
A new episode is defined as no prior diagnosis of depression of any magnitude (ICD-9 codes 296.2-296.9, 298.0, 300.4, 309.0, 309.1, 309.28, 311) within 120 days of the first episode occurring during the study year.
Please refer to HEDIS technical specifications for a more thorough discussion of measure requirements.
Return to Previous Measure
Return to Measures Specifications Appendix
Proceed to Next Measure
Return to Contents